Catalyst (CPRX) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2025, Catalyst Pharmaceutical (CPRX) reported revenue of $152.61 million, up 7.6% over the same period last year. EPS came in at $0.68, compared to $0.70 in the year-ago quarter.The reported revenue represents a surprise of +9% over the Zacks Consensus Estimate of $140.02 million. With the consensus EPS estimate being $0.42, the EPS surprise was +60.95%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to ...